Cargando…
Combination of verteporfin-photodynamic therapy with 5-aza-2’-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer
INTRODUCTION: Triple negative breast cancer (TNBC) is a subtype of breast cancer characterised by its high tumourigenic, invasive, and immunosuppressive nature. Photodynamic therapy (PDT) is a focal therapy that uses light to activate a photosensitizing agent and induce a cytotoxic effect. 5-aza-2’-...
Autores principales: | Banerjee, Shramana M., Acedo, Pilar, El Sheikh, Soha, Harati, Rania, Meecham, Amelia, Williams, Norman R., Gerard, Gareth, Keshtgar, Mohammed R. S., MacRobert, Alexander J., Hamoudi, Rifat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664979/ https://www.ncbi.nlm.nih.gov/pubmed/38022682 http://dx.doi.org/10.3389/fimmu.2023.1188087 |
Ejemplares similares
-
Photodynamic Therapy in Primary Breast Cancer
por: Banerjee, Shramana M., et al.
Publicado: (2020) -
Photodynamic Therapy with Verteporfin for Corneal Neovascularization
por: Al-Torbak, Abdullah A.
Publicado: (2012) -
miR-623 Targets Metalloproteinase-1 and Attenuates Extravasation of Brain Metastatic Triple-Negative Breast Cancer Cells
por: Hammash, Dua, et al.
Publicado: (2022) -
The antileukaemic activity of 5-Aza-2 deoxycytidine (Aza-dC) in patients with relapsed and resistant leukaemia.
por: Richel, D. J., et al.
Publicado: (1991) -
Photodynamic Therapy With Verteporfin for Choroidal Neovascularization in Patients with Angioid Streaks
por: Lee, Jun Mok, et al.
Publicado: (2007)